Watch Demo

South Korea Anti-Infective Industry Outlook 2022 - 2026

See how South Korea Anti-Infective performed compared to key markets such as the United Kingdom and Germany.

Key Market Indicators

Sales of antiinfective medicines in South Korea are forecasted to hit $3.3 billion by 2026, growing at an average rate of 1.4% year-on-year since 2013. In 2021, Germany topped the list with $3.1 billion, while South Korea, Italy and Germany ranked second, third and fourth respectively. Korean imports of antibiotics are set to reach $275 million by 2026, up 1.2% year-on-year since 1993. Exports of antibiotics from South Korea are projected to reach $302 million by 2026, growing 1.3% year-on-year since 1993. In 2021, Ireland overtook South Korea with exports worth $284 million. Switzerland, Italy and India occupied 2nd, 3rd and 4th places respectively.

Marketing Banner

South Korea Anti-Infective Market Data and Forecasts

How much will South Korea Anti-Infective Market grow to 2026?

Forecast: Antibacterial Medicine Use in South Korea
Forecast: Antiinfective Medicine Sales in South Korea
Forecast: Antibacterial Medicine Sales in South Korea
Forecast: Antibacterial Medicine Sales in South Korea
Forecast: Antiinfective Medicine Sales in South Korea
More in Anti-Infective Industry for 2028

Improve your Knowledge with the latest Indicators and Trends